Hero image with Pittsburgh background https://pittplusme.org/study/2235

STUDY BASICS

Young adults between the ages of 18 and 26, with current depression are needed for a research study to help understand how a brain stimulation technique, Theta Burst Stimulation (TBS), may contribute to enhancing positive affect in young adults with depression. This study involves an interview and questionnaire, computer tasks, brain stimulation, and brain imaging scans. Compensation provided.


STUDY PURPOSE

The purpose of this study is to help researchers understand how theta burst stimulation (TBS) and positive affect can be enhanced in young adults with depression.


COULD THIS STUDY BE RIGHT FOR YOU?
  • A young adult between the ages of 18-26
  • Experiencing current depression
  • Willing to undergo Theta Burst Stimulation and fMRI scans
 

 


WHAT PARTICIPANTS CAN EXPECT

This study involves 10 in-person visits conducted over 2 weeks and 2 remote visits (one eligibility visit, one follow-up). Visits include computer tasks, interviews, brain stimulation, and fMRI scan. The fMRI is an imaging technique that measures and maps brain activity.  These visits do not involve radiation and is non-invasive.


IRB: STUDY21060041
- Treatment, Emotion, and Neuromodulation of Depression (TREND) Study

PHONE NUMBER: 1-866-438-8230
SHARE STUDY
Printer Printer   Email A FriendEmail A Friend   ShareShare   TweetTweet   Linked-InLinked-In

INTERESTED?

Visit https://pittplusme.org/study/2235 and click on "I'm Interested" or call 1-866-438-8230.


LEARN MORE

PittPlusMe.org
1-866-438-8230
PittPlusMe@pitt.edu
@PittPlusMe
@PittPlusMe

MEET THE RESEARCHER


Erika Forbes

Erika E. Forbes, PhD, is associate professor of psychiatry, psychology, and pediatrics at the University of Pittsburgh. Dr. Forbes is a specialist in the field of depression, especially regarding reward-related brain functioning in adolescents. Her research has been published in a number of leading publications. She has received awards and honors from the University of Pittsburgh, American College of Neuropsychopharmacology, National Alliance for Research on Schizophrenia and Depression, and the National Institute of Health.